- Home
- HOUR vs NRXP Comparison
HOUR vs NRXP Comparison
Compare HOUR & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOUR | NRXP |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 54.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOUR | NRXP |
|---|---|---|
| Price | $1.91 | $1.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $31.50 |
| AVG Volume (30 Days) | 10.9K | ★ 497.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.57 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $138,252,861.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $847.91 |
| P/E Ratio | $27.14 | ★ N/A |
| Revenue Growth | ★ 4.64 | N/A |
| 52 Week Low | $1.10 | $1.58 |
| 52 Week High | $6.84 | $3.84 |
Technical Indicators
Market Signals| Indicator | HOUR | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 49.93 |
| Support Level | $1.75 | $1.65 |
| Resistance Level | $1.95 | $1.99 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 35.03 | 63.49 |
Price Performance
Historical ComparisonAbout HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.